SCHEMBL25344672

SCHEMBL25344672

COCc1cc(F)ccc1-n1ncc2c(Cl)ncnc21

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 8/20 0.45
SLC2A3 P11169 8/20 0.45
SLC2A2 P11168 3/20 0.45
TP53 P04637 4/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
CYP17A1 P05093 1/20 0.41
CYP1A2 P05177 1/20 0.41
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 1/20 0.39
PIP4K2A P48426 2/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25344048 0.85 TP53 (0.42) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL25344741 0.85 SLC2A1 (0.56) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL25342411 0.81 HTT (0.54) TP53LMNAPOLBCYP17A1CYP1A2
SCHEMBL25343109 0.81 SLC2A1 (0.45) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL30568414 0.80 CYP17A1 (0.53) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL839701 0.80 CYP17A1 (0.53) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL839044 0.80 CYP17A1 (0.55) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL25343909 0.78 CYP17A1 (0.42) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL25343463 0.78 TP53 (0.44) SLC2A1SLC2A3SLC2A2TP53LMNA
SCHEMBL838540 0.78 TP53 (0.57) SLC2A1SLC2A3SLC2A2TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472739-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-12-11 EP disclosed
WO-2023148129-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-08-10 WO disclosed